| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.66▲ | 2.67▼ | 2.67▼ | 2.72▼ | 2.81▼ |
| MA10 | 2.67▲ | 2.70▼ | 2.71▼ | 2.83▼ | 3.03▼ |
| MA20 | 2.69▼ | 2.71▼ | 2.70▼ | 2.82▼ | 3.06▼ |
| MA50 | 2.71▼ | 2.72▼ | 2.79▼ | 3.05▼ | 3.15▼ |
| MA100 | 2.70▼ | 2.82▼ | 2.84▼ | 3.03▼ | 3.09▼ |
| MA200 | 2.79▼ | 2.83▼ | 2.80▼ | 2.98▼ | 3.32▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.006▼ | 0.000▼ | -0.006▼ | -0.055▼ |
| RSI | 41.848▼ | 40.935▼ | 39.259▼ | 39.859▼ | 42.843▼ |
| STOCH | 14.815▼ | 7.576▼ | 11.724▼ | 20.368 | 17.463▼ |
| WILL %R | -71.429 | -85.714▼ | -85.714▼ | -91.667▼ | -91.698▼ |
| CCI | -58.333 | -103.467▼ | -122.439▼ | -106.617▼ | -95.655 |
|
Tuesday, October 13, 2026 06:01 AM
Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...
|
|
Tuesday, October 13, 2026 05:40 AM
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Jose Conejo-Garcia, MD, PhD, inventor ...
|
|
Monday, October 05, 2026 06:15 AM
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/26 | 2.79 | 2.8199 | 2.645 | 2.67 | 123,315 |
| 15/10/26 | 2.66 | 2.79 | 2.63 | 2.78 | 223,300 |
| 14/10/26 | 2.75 | 2.82 | 2.63 | 2.66 | 228,400 |
| 13/10/26 | 2.84 | 2.8401 | 2.66 | 2.67 | 175,294 |
| 12/10/26 | 2.90 | 2.92 | 2.83 | 2.84 | 97,700 |
| 09/10/26 | 2.93 | 2.96 | 2.86 | 2.90 | 217,779 |
| 08/10/26 | 2.93 | 2.93 | 2.8611 | 2.91 | 256,823 |
| 07/10/26 | 3.01 | 3.0559 | 2.93 | 2.95 | 245,242 |
| 06/10/26 | 2.95 | 3.11 | 2.87 | 3.02 | 344,900 |
| 05/10/26 | 2.98 | 2.99 | 2.875 | 2.95 | 369,337 |
|
|
||||
|
|
||||
|
|